Mediterranean Diet and Bacterial Translocation and Immune-activation in Patients With HIV

Inclusion Criteria: * Patient ≥ 18 years of age; * To sign voluntary informed consent; * Male or female patients with a negative pregnancy test before inclusion in the study; * Proven HIV infection (with HIV-1 positive antibodies); * Patient should be on stable treatment with cART for at least 1 year * The mean of all CD4 measurements during the year prior to the initiation of cART should be equal to greater than 350 cells / mm3 * The number of CD4 + at the time of recruitment must be equal to or greater than 500 cells / mm3; * HIV viral load should be undetectable at least 6 months prior to study inclusion, and less determinations (occasional blips above the undetectable level are allowed). Exclusion Criteria: * Acquired Immunodeficiency Syndrome. * Active opportunistic diseases. * Patients coinfected with HCV or HBV * Coagulopathy * Renal insufficiency (creatinine\> 1.5 mg / dL) * Pregnancy or breastfeeding * Inability to sign informed consent * Active opportunistic infections, or any active infection or cancer within 30 days prior to the screening visit; * Therapy with immunomodulatory agents, including cytokines (eg IL-2) and gammaglobulins or chemotherapy within 90 days prior to the screening visit; * Use of anticoagulant medication; * Use of any type of experimental medication during the 90 days prior to study entry; * Uncontrolled psychiatric disorder; * Patients with uncontrolled active autoimmune diseases; * Usual use of antibiotics